Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

Background & Aims: Serum sodium (Na) concentrations have been suggested as a useful predictor of mortality in patients with end-stage liver disease awaiting liver transplantation. Methods: We evaluated methods to incorporate Na into model for end-stage liver disease (MELD), using a prospective,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2006-05, Vol.130 (6), p.1652-1660
Hauptverfasser: Biggins, Scott W., Kim, W. Ray, Terrault, Norah A., Saab, Sammy, Balan, Vijay, Schiano, Thomas, Benson, Joanne, Therneau, Terry, Kremers, Walter, Wiesner, Russell, Kamath, Patrick, Klintmalm, Goran
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background & Aims: Serum sodium (Na) concentrations have been suggested as a useful predictor of mortality in patients with end-stage liver disease awaiting liver transplantation. Methods: We evaluated methods to incorporate Na into model for end-stage liver disease (MELD), using a prospective, multicenter database specifically created for validation and refinement of MELD. Adult, primary liver transplant candidates with end-stage liver disease were enrolled. Results: Complete data were available in 753 patients, in whom the median MELD score was 10.8 and sodium was 137 mEq/L. Low Na (
ISSN:0016-5085
1528-0012
DOI:10.1053/j.gastro.2006.02.010